Emerging Diseases and Outbreaks

Emerging Diseases and Outbreaks

Global

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
101-120 of 176 ARTICLES
https://doi.org/10.12688/f1000research.51210.3
Research Article metrics
Revised
An exploratory study of social media users’ engagement with COVID-19 vaccine-related content
[version 3; peer review: 2 approved]
Peer Reviewers Jayaseelan Rathinaswamy; Arriel Benis
LATEST VERSION PUBLISHED 23 Jun 2021
https://doi.org/10.12688/f1000research.25522.2
Systematic Review metrics
Update
The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: update of living systematic review
[version 2; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Lakshmi Vijayakumar; Kimberly A Van Orden; Gonzalo Martinez-Ales
  • Funders
  • NIHR Greater Manchester Patient Safety Translational Research Centre
  • Swansea University
  • University of Bristol
  • National Institute for Health Research
  • Oxford University Hospitals NHS Foundation Trust
  • Cochrane Satellite for Suicide and Self-Harm Prevention
  • National Centre for Mental Health
  • NIHR Bristol Biomedical Research Centre
  • NIHR Applied Research Collaboration West
LATEST VERSION PUBLISHED 17 Jun 2021
https://doi.org/10.12688/f1000research.24591.2
Research Article metrics
Revised
Clinical trials for treatment or prevention of COVID-19. A review of Clinicaltrials.gov.
[version 2; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Ana Marusic; Andrea Cortegiani
LATEST VERSION PUBLISHED 16 Jun 2021
https://doi.org/10.12688/f1000research.51590.3
Systematic Review metrics
Revised
SARS-CoV-2 and the role of fomite transmission: a systematic review
[version 3; peer review: 2 approved]
Peer Reviewers Emanuel Goldman; Ana Karina Pitol Garcia
  • Funder
  • World Health Organization
LATEST VERSION PUBLISHED 14 Jun 2021
https://doi.org/10.12688/f1000research.50857.2
Brief Report metrics
Revised
Interactive SARS-CoV-2 mutation timemaps
[version 2; peer review: 3 approved]
Peer Reviewers Ingo Ebersberger and Ruben Iruegas; Takahiko Koyama; Jale Moradi
  • Funders
  • National Institute for Health Research
  • Genome Canada
LATEST VERSION PUBLISHED 03 Jun 2021
https://doi.org/10.12688/f1000research.36396.3
Research Article metrics
Revised
Association between convalescent plasma and the risk of mortality among patients with COVID-19: a meta-analysis
[version 3; peer review: 2 approved]
Peer Reviewers Morteza Arab-Zozani; Guilherme Welter Wendt
LATEST VERSION PUBLISHED 02 Jun 2021
https://doi.org/10.12688/f1000research.52491.1
Research Article metrics
A review of the Cochrane COVID-19 Study Register reveals inconsistency in the choice and measurement of SARS-CoV-2 infection outcomes in prevention trials
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Natasha Tyler; Michael Samarkos
  • Funders
  • National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol
  • the Royal College of Surgeons of England Bristol Surgical Trials Centre
  • National Institute for Health Research (NIHR) Senior Investigator Award
PUBLISHED 28 May 2021
https://doi.org/10.12688/f1000research.27495.2
Data Note metrics
Revised
A dataset for the analysis of antibody response to glycan alpha-Gal in individuals with immune-mediated disorders
[version 2; peer review: 2 approved, 1 not approved]
Peer Reviewers Jacques Le Pendu; Tilo Biedermann; Mona Mahmoud
  • Funder
  • Consejería de Educación, Cultura y Deportes, JCCM
LATEST VERSION PUBLISHED 25 May 2021
https://doi.org/10.12688/f1000research.52381.1
Review metrics
COVID-19 associated spontaneous barotrauma: a literature review
[version 1; peer review: 2 approved with reservations, 1 not approved]
Peer Reviewers Philippe Jouvet; Kapil Dev Soni; Giacomo Monti
PUBLISHED 21 May 2021
https://doi.org/10.12688/f1000research.50850.3
Research Article metrics
Revised
Identifying potential drug targets and candidate drugs for COVID-19: biological networks and structural modeling approaches
[version 3; peer review: 3 approved]
Peer Reviewers Sugunadevi Sakkiah; Dhurvas C. Dinesh; Turanli Beste
  • Funders
  • Natural Sciences and Engineering Research Council of Canada
  • Ministry of Science and Technology of the People's Republic of China
  • Concordia University
  • National Natural Science Foundation of China
  • MITACS Global Research
LATEST VERSION PUBLISHED 17 May 2021
https://doi.org/10.12688/f1000research.52178.1
Brief Report metrics
Multi-modality detection of SARS-CoV-2 in faecal donor samples for transplantation and in asymptomatic emergency surgical admissions
[version 1; peer review: 2 approved]
Peer Reviewers Jonathan Landy; James Kinross
  • Funders
  • Cancer Research UK
  • Birmingham Experimental Cancer Medicine Centre
  • CRUK Centre Birmingham
PUBLISHED 11 May 2021
https://doi.org/10.12688/f1000research.27324.2
Brief Report metrics
Revised
Studying the prominence effect amid the COVID-19 crisis: implications for public health policy decision-making.
[version 2; peer review: 2 approved]
Peer Reviewers Roshen Fernando; Peterson K Ozili
LATEST VERSION PUBLISHED 07 May 2021
https://doi.org/10.12688/f1000research.23524.3
Research Article metrics
Revised
Revisiting early-stage COVID-19 strategy options
[version 3; peer review: 2 approved]
Peer Reviewers Siddharth Sridhar; Agata Mikolajczyk
LATEST VERSION PUBLISHED 23 Apr 2021
https://doi.org/10.12688/f1000research.51164.1
Brief Report metrics
The feasibility of targeted test-trace-isolate for the control of SARS-CoV-2 variants
[version 1; peer review: 2 approved with reservations]
Peer Reviewers Akira Endo; Tim C. D. Lucas
  • Funders
  • Drexel Endowment
  • Centers for Disease Control and Prevention
  • Open Philanthropy Project
  • Reid Hoffman Foundation
  • COVID-19 HPC consortium
PUBLISHED 16 Apr 2021
https://doi.org/10.12688/f1000research.51786.1
Review metrics
Is butyrate a natural alternative to dexamethasone in the management of CoVID-19?
[version 1; peer review: 3 approved]
Peer Reviewers Mallika Valapala; Stephen O. Mathew; Harishkumar Madhyastha
PUBLISHED 06 Apr 2021
https://doi.org/10.12688/f1000research.51357.1
Method Article metrics
COVID-19 and digital transformation: developing an open experimental testbed for sustainable and innovative environments using Fuzzy Cognitive Maps
[version 1; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Peter Zeile; Tamás Molnár; Chrysostomos D. Stylios
  • Funder
  • TUM Publishing Fund for Open Access Publishing
PUBLISHED 01 Apr 2021
https://doi.org/10.12688/f1000research.29977.1
Opinion Article metrics
Conducting qualitative research during COVID-19: reflections on methods and challenges when interviewing marginalized refugee women
[version 1; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Sukhjeet Bains; Khangelani Moyo
  • Funders
  • Aga Khan University
  • International Organisation of Migration
PUBLISHED 11 Mar 2021
https://doi.org/10.12688/f1000research.27334.2
Systematic Review metrics
Revised
Global prevalence and pathogenesis of headache in COVID-19: A systematic review and meta-analysis
[version 2; peer review: 2 approved]
Peer Reviewers Erni J. Nelwan; Morteza Arab-Zozani
LATEST VERSION PUBLISHED 10 Mar 2021
https://doi.org/10.12688/f1000research.45046.1
Systematic Review metrics
Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis
[version 1; peer review: 1 approved, 2 approved with reservations]
Peer Reviewers Lorenzo Cosmi; Wiwien Heru Wiyono; Zhongheng Zhang
PUBLISHED 04 Feb 2021
https://doi.org/10.12688/f1000research.36371.1
Research Article metrics
Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2
[version 1; peer review: 2 approved]
Peer Reviewers Sivaraman Natarajan; Tirumala Bharani K. Settypalli
PUBLISHED 23 Jan 2021
101-120 of 176 ARTICLES
Gateway Areas
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.